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Abstract
Background: Osteolytic metastases around the acetabulum are frequent in tumour patients, and may
cause intense and drug-resistant pain of the hip. These lesions also cause structural weakening of the pelvis,
limping, and poor quality of life. Percutaneous acetabuloplasty is a mini-invasive procedure for the
management of metastatic lesions due to carcinoma of the acetabulum performed in patients who cannot
tolerate major surgery, or in patients towards whom radiotherapy had already proved ineffective.
Methods: We report a retrospective study in 25 such patients (30 acetabuli) who were evaluated before
and after percutaneous acetabuloplasty, with regard to pain, mobility of the hip joint, use of analgesics, by
means of evaluation forms: Visual Analog Scale, Harris Hip Score, Western Ontario and McMaster
Universities Index of Osteoarthritis (WOMAC), Eastern Cooperative Oncology Group (ECOG). The
results obtained were analysed using the χ2 Test and Fisher's exact test. Significance was sent at P < 0.05.
Results: Marked clinical improvement was observed in all patients during the first six post-operative
months, with gradual a worsening thereafter from deterioration of their general condition.
Complete pain relief was achieved in 15 of our 25 (59%) of patients, and pain reduction was achieved in
the remaining 10 (41%) patients. The mean duration of pain relief was 7.3 months. Pain recurred in three
patients (12%) between 2 weeks to 3 months. No major complications occurred. There was transient local
pain in most cases, and 2 cases of venous injection of cement without clinical consequences.
Conclusion: Percutaneous acetabuloplasty is effective in improving the quality of life of patients with
osteolytic bone tumours, even though the improvement is observed during the first 6 months only. It can
be an effective aid to chemo- and radiotherapy in the management of acetabular metastases.
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Background
Osteolytic metastases around the acetabulum are frequent
in tumour patients, and may cause intense and drug-
resistant pain of the hip. These lesions also cause struc-
tural weakening of the pelvis, limping, and poor quality of
life. Such patients may require walking aids, and are often
wheelchair-bound. The osteolytic lesions often lead to
pathological fractures, forcing the patients to bed rest,
with a considerable increase of co-morbidity.
Radiotherapy alone is usually unable to control the pain
and/or to restore the integrity of the acetabular area, so as
to allow a return to early weight-bearing [1,2]. Acetabular
reconstruction is invasive, and carries a high rate of local
and systemic complications in patients with multiple
metastases [3,4]. Acrylic cement has been used to fill sec-
ondary benign or malignant osteolytic lesions of the long
bones after curettage [5,6]. Vertebroplasty and kypho-
plasty are able to obtain reduction or the elimination of
pain by injection of acrylic cement into the pathological
or osteoporotic fractures of the spine [7-10]. Similar tech-
niques have been reported in the management of meta-
static lesions around the acetabulum [11,12]. We report
the results of a retrospective study on 25 patients with
acetabular metastases, who received percutaneous acetab-
uloplasty.
Methods
Patients
In the period January 2004 to March 2007, 25 patients (30
acetabular lesions) gave their written informed consent to
undergo percutaneous acetabuloplasty. All patients pre-
senting with metastatic acetabular disease were evaluated
by a multidisciplinary team, which included oncologists,
radiotherapists, orthopaedic surgeons and radiologists.
Patients received the procedure if it was not possible to
perform surgical reconstruction of the acetabulum. The
inclusion and exclusion criteria are reported in Table 1
and 2(a, b).
All patients were evaluated before and 1, 3, 6, 12 months
after acetabuloplasty with regard to pain, hip joint mobil-
ity, use of analgesics using the following criteria Visual
Analog Scale, Harris Hip Score, Western Ontario and
McMaster Universities Index of Osteoarthritis (WOMAC),
Eastern Cooperative Oncology Group (ECOG). Also the
type and quantity of drugs taken by the patients to control
the pain, during the preoperative and postoperative peri-
ods, were recorded.
Twenty-five patients (30 acetabuli: 11 males and 14
female; average age 59.9 years; left side affected in 17
instances, right side affected in 13 instances) underwent
the index procedure. At the time of percutaneous acetabu-
loplasty, nine biopsies were performed using the same set
of instruments (Stryker Corp. Kalamazoo, MI, USA). In
two patients, together with acetabuloplasty, a bipolar
hemiarthroplasty was implanted for a transcervical frac-
ture of the femoral neck (fig 1). In three other patients, a
reconstruction intramedullary locked nail was implanted
for a fracture or an impending fracture of the femoral dia-
physis (fig 2). The primary tumour originated from the
breast (15 patients), lung (8 patients), prostate (2
patients). The presence of an osteolytic acetabular lesion
was evaluated preoperatively by standard radiography, CT
and MRI. (fig 3, 4, 5). Postoperatively standard radiogra-
phy and CT were performed (fig 6, 7)
Operative technique
The procedure was performed under general (n = 7
patients), spinal (n = 15 patients) or local anaesthesia (n
= 3 patients). Patients are positioned on a fracture table
either supine or in lateral decubitus, and antero-lateral
and postero-lateral portals are used to fill the whole cavity
with cement. After having prepared a sterile field, two Kir-
schner wires are inserted into the acetabulum under image
intensifier control. Using the two Kirschner wires as an
initial guide, two appropriately sized introducer cannulae
are slid over these Kirschner wires for cement injection
(e.g. 10 Gauge), and inserted into the osteolytic cavity.
The Kirschner wires are removed, and the cannula may be
oriented with its bevelled stylet for subsequent cement
injection in the desired location. If desired, prior to inject-
ing the cement, a percutaneous bone biopsy can be taken
using another cannula in conjunction with the introducer
cannula (Stryker Bone Byopsy Kit, Stryker Corp Kalama-
zoo, MI, USA). This allows to obtain a small cylindrical
sample of tissue. The positioning of the cannula and the
Table 1: Indications to acetabuloplasty
Weight-bearing acetabular osteolisis
Hip pain resistant to drugs
Patients with multiple metastases
Short life expectancy
Inability to tolerate major surgery
Histotype differing from that of the kidney and the thyroid gland
Radioterapy ineffectiveness
Table 2: 
a: Absolute contraindications to acetabuloplasty
Acetabular fracture
Pelvic discontinuity
b: Relative contraindications to acetabuloplasty
Radiographic signs of medial wall interruption
Local infection
Hemorrhagic disordersBMC Musculoskeletal Disorders 2008, 9:66 http://www.biomedcentral.com/1471-2474/9/66
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injection of the cement are constantly monitored in
antero-posterior and oblique projections. While the
cement is being injected, no leakage should occur outside
of the bone. Should this be observed, the cement injection
should be stopped, and the cannula may have to be with-
drawn, so as to allow the cement that has already been
injected to harden, and to avoid any further leakage. At a
later stage, more cement can be injected, if necessary.
Some authors suggest to inject contrast medium before
using the cement, to see how this will spread inside the
osteolytic lesion [13]. This was not performed in this
study. If the cement leaks in the hip joint, in addition to
Illustrative images of patients with fracture of the femoral  neck and acetabular osteolysis managed with bipolar endo- prosthesis and acetabuloplasty Figure 1
Illustrative images of patients with fracture of the 
femoral neck and acetabular osteolysis managed 
with bipolar endoprosthesis and acetabuloplasty.
Femoral and acetabular osteolysis treated with a locked  intramedullary reconstruction nail and acetabuloplasty Figure 2
Femoral and acetabular osteolysis treated with a 
locked intramedullary reconstruction nail and 
acetabuloplasty.
Preoperative plain radiographs showing wide acetabular  osteolysis Figure 3
Preoperative plain radiographs showing wide acetab-
ular osteolysis.BMC Musculoskeletal Disorders 2008, 9:66 http://www.biomedcentral.com/1471-2474/9/66
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stopping the injection, the leg is brought to the whole
range of motion, so as to spread the leaked cement over
the surface of the joint before it hardens.
If the patients received general or spinal anaesthesia, they
were positioned in lateral or supine decubitus. If local
anaesthesia was used (10 ml of 7.5 mg of ropivacaine
mixed with 10 ml of 1% mepivacaine, AstraZeneca S.p.A.
– Italia,), the patient was supine. All procedures were per-
formed by the same surgeon. Each patient received 2 g of
intravenous cefazolin 30 minutes before surgery. The
average length of time of the procedure was 30 minutes.
The average hospital stay was 3 days.
Statistics
Descriptive statistics were calculated. The results obtained
were analysed using the χ2 Test and Fisher's exact test.
Singificance was sent at P < 0.05.
Results
In all patients, mechanical stabilization of the osteolytic
lesion was achieved, there were no pathological fractures,
CT Figure 4
CT.
MRI of the corresponding area Figure 5
MRI of the corresponding area.
Postoperative plain radiographs Figure 6
Postoperative plain radiographs.BMC Musculoskeletal Disorders 2008, 9:66 http://www.biomedcentral.com/1471-2474/9/66
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and no clinical symptoms related to cement leakage. Eight
patients reported transiently increased pain of the hip and
pyrexia in the immediate postoperative 48 hours. In two
patients, the cement was injected in a vessel, but there
were no clinical manifestations of this. The images were
reviewed by a fellowship trained interventional radiolo-
gist who, in the absence of clinical symptoms, did not
require any further imaging.
An overall improvement of the quality of life of the
patients was evident, and patients were able to return to
their activities of daily living (fig. 8, 9, 10, 11). The
WOMAC hip questionnaire showed marked local
improvement. The ECOG index showed an improvement
of the patients' general condition up to 6 months after the
index procedure, with the average score improving from
3.44 preoperatively, to 2.00 at 1 month, 1.24 at 3 months,
and 1.84 at 6 months. Worsening of the general condition
was observed one year after the surgery, with an average
score of 3.76, with 10 patients dead by that time. The HHS
index showed an improvement in the ability to carry out
standard daily activities autonomously, with a preopera-
tive score of 34.60% rising to a postoperative score of
72.75% one month after the intervention, which further
improved (81.79%) 3 months after the treatment. At the
1 year follow-up a worsening of the general condition was
observed, with reduced autonomy, with the average HHS
score dropping to 59.16%, yet still higher than the score
recorded preoperatively. A similar trend was observed for
pain, measured by the VAS score. Pain improved from an
average preoperative score of 8.60 to 2.84 at 1 month, to
2.12 at 3 months, to 2.45 at 6 months, and to 5.06 at 1
year. The local function, evaluated by the WOMAC,
showed a considerable improvement over the first 6
months after the treatment, from an average preoperative
score of 78.80% to 39.17% at 6 months. One year after
the injection, the local function dropped to an average
score of 55.31%.
In summary, complete pain relief was achieved in 59% of
patients (n = 15). Pain reduction was achieved in 10 of 25
patients (41%). The mean duration of pain relief was 7.3
months (median: 6 months). Pain recurred in three
patients (12%) between 2 weeks to 3 months. Ten
patients died, and 15 patients were still alive at the time of
the one year follow up. The one-year survival rate was
40% (observation period: 1–30 months). No major com-
plications occurred. There was transient local pain in most
cases, and 2 cases of venous injection of cement without
clinical consequences (fig. 12).
We observed a reduction or, in some patient, the cessation
of analgesic drug assumption, compared to the preopera-
tive period. It is impossible to quantify the reduction of
analgesic drug assumption in patients with systemic neo-
plastic disease, due to the coexistence of multiple second-
ary lesions. Nevertheless, a marked reduction of analgesic
drug assumption was observed in some (4 patients, 16%),
even when radiotherapy was not effective.
CT showing filling of the acetabular lesion Figure 7
CT showing filling of the acetabular lesion.
Eastern Cooperative Oncology Group (ECOG) values  Patients: n = 25; p < 0.001 Figure 8
Eastern Cooperative Oncology Group (ECOG) val-
ues Patients: n = 25; p < 0.001.
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Discussion
Surgical reconstruction in metastatic disease of the acetab-
ulum should fulfil three aims: resection of the tumour,
filling of the bone defect, and stabilization of the skeletal
segment. Usually, the lesion is curetted, followed by fill-
ing with cement and reinforcement with Steinman pins,
or the use of a hip or pelvic prosthesis [3]. Although these
procedures have a high rate of complications, and a death
rate of about 50% within 12 months [4], the patient's life
expectancy and the improvement of the quality of life pro-
duced justify the surgical risks.
Radiotherapy is indicated for bone pain caused either
directly or indirectly by malignant lesions. Malignant
lesions may produce pain from direct action on the nerv-
ous system [14]. However, different modalities of pain
production may act in the presence of skeletal metastases
(mild, moderate, mechanical) [15]. Injection of cement
may immediately reduce pain in patients with acetabular
metastases in the absence of protrusion or fracture, with at
least partial pain relief in about 80% of patients
[1,2,16,17] within two weeks of the injection. Radiother-
apy does not improve the mechanical properties of the
affected acetabular region, and transient osteoporosis is
usually observed, with the risk of pathological fractures
[1,2].
In 1995, Cotten [11] suggested to extend the vertebro-
plasty technique to the acetabulum for the management
of secondary osteolytic lesions. Preliminary results
showed that these techniques were effective as palliative
methods for controlling pain and reinforcing bone.
Acetabuloplasty uses a percutaneous injection of low vis-
cosity acrylic cement into the osteolytic cavity of acetabu-
lum. Acetabuloplasty aims to immediately restore the
mechanical properties of the affected skeletal segment, it
imparts increased resistance to compressive stresses to the
treated acetabulum with prevention of continue micro-
trauma responsible of the increased risk of fractures,
allowing immediate weight-bearing and preventing path-
ological fractures. It also reduces or eliminates pain. Fur-
thermore, the exothermic reaction developed during the
polymerization of the cement exerts a local cytotoxic
action against the tumour. Acetabuloplasty is indicated in
patients suffering from acetabular metastatic disease of
the weight-bearing area, with drug-resistant pain of the
hip, gait limitation and inability to tolerate major surgery,
Harris Hip score Figure 9
Harris Hip score. Patients: n = 25; p < 0.001.
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Visual Analogue Pain (VAS) scale for pain Figure 10
Visual Analogue Pain (VAS) scale for pain. Patients: n 
= 25; p < 0.001.
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Patients: n = 25; p < 0.001.
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either from a local or systemic extension of the disease, or
particularly poor clinical condition (fig. 3, 4, 5, 6, 7). Hip
fractures are not a contraindication, and the opportunity
to use a bipolar endoprosthesis combined with the injec-
tion of acetabular cement allows a mechanical support for
the acetabulum. This enables the patient to avoid the risk
of haemorrhage, and the problems linked to the prepara-
tion of the acetabulum. The same considerations can be
made for combined lesions of the femoral shaft and the
acetabulum, and for patients with bilateral disease. (fig. 1,
2, 12).
Acetabuloplasty can aid radiotherapy, both by improving
pain and by providing a mechanical support at a stage
during which radiotherapy alone would not be able to
prevent pathological fractures. Complications may also
occur in pelvic cementoplasty (Table 3), but, in our expe-
rience, they were only relatively minor.
Following acetabuloplasty, our patients experienced
marked pain relief and increased ability to walk, a return
to normal daily and recreational activities, and an overall
increase of quality of life. Acetabuloplasty seems to
achieve the main goals of palliative management, namely
improving clinical conditions using a low risk low cost
procedure.
The mean duration of pain relief was 6 months. After that
period, worsening of the patients' condition from progres-
sion of the disease influenced also the local results. At 1
year after acetabuloplasty, 10 patients had died from inev-
itable progression of the underlying conditions, 15
patients were still alive, with only one patient lost to fol-
low-up. No major complications were observed.
To the best of the authors' knowledge, this present is the
largest study to date. This retrospective study presents
some limits. For this reason, prospective studies compar-
ing cement injection with other minimally invasive tech-
niques (chemoablation, cryoablation, thermal ablation)
are desirable.
Following Cotten's experience, others have also used
acetabuloplasty, obtaining above all an immediate
improvement of the pain symptom after the injection,
both in individual cases [13,18-21] and in larger series.
Some have suggested a combined approach, with radiof-
requency thermal ablation and percutaneous cemento-
plasty [22,23]. Toyota et al [22] reported on 17 adult
patients with 23 painful bone metastases who underwent
RF ablation therapy combined with cementoplasty over a
2-year period.
Schaefer [23] described a patient with a stage IV malignant
melanoma and a pathological fracture of the left tibial
plateau who underwent radiofrequency heat ablation and
percutaneous cementoplasty for defect filling and stabili-
zation. The exothermic reaction arising from the cement's
polymerization is basically the same as that obtained by
radiofrequency. Therefore, no increase of cytotoxic effect
on the tumour should be obtained [23].
Acetabuloplasty is reliable for the management of acetab-
ular osteolysis in patients who cannot be candidate to
major surgery. In patients in whom radiotherapy was not
effective, it can be performed by orthopaedic surgeons
and interventional radiologists. In selected patients, local
anaesthesia may be used. The contemporary presence of
an impending or complete femoral fracture should be an
indication for acetabular cementoplasty during the same
anaesthesia.
This study cannot demonstrate that acetabuloplasty
results in reduction of analgesic drugs in patients with
multiple metastases, or whether the technique is superior
to percutaneous radiofrequency. Nevertheless, bone
cement is able to restore some of the compromised
mechanical proprieties after filling bone cavities. Peria-
cetabular defects may increase the vulnerability of the pel-
vis to fracture [24], depending on size and cortical
involvement. Acetabular cement filling may lower the risk
of periacetabular fractures, as little as 10% cement by vol-
Bilateral metastatic osteolisys, showing vascular injection of  the cement Figure 12
Bilateral metastatic osteolisys, showing vascular 
injection of the cement.
Table 3: Known complications of acetabuloplasty
Post operative pain and fever (1–4 days)
Intrarticular injection
Vessel injection
Long-distance failure (progressive disease)
Renal failureBMC Musculoskeletal Disorders 2008, 9:66 http://www.biomedcentral.com/1471-2474/9/66
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ume could result in large compressive strength increases,
thus reducing the risk of fractures. [25]
A randomized prospective study comparing the results
between radiotherapy, radiofrequency and cementoplasty
should be considered in the future.
Conclusion
Percutaneous acetabuloplasty is a palliative mini-invasive
technique that produces effective results in the manage-
ment of acetabular osteolyses in patients with multiple
metastases and with a low life expectancy. Percutaneous
acetabuloplasty is effective in improving the quality of life
of patients with osteolytic bone tumours, even though the
improvement is observed during the first six months only.
It can be an effective aid to chemo- and radiotherapy in
the management of acetabular metastases.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
GM operated patients, conceived the study. FL drafted the
manuscript. LS performed statistical analysis and partici-
pated in drafting. AM performed statistical analysis. FM
participated in design of the study. BR followed patients.
WV revised manuscript. GL followed patients. CAL coor-
dinated group. NM participated in design and drafting
and revised manuscript. All authors read and approved
the final manuscript.
References
1. Gilbert HA, Kagam AR, Nussbaum H: Evaluation of radiation
therapy for bone metastases: pain relief and quality of life.
AJR 1977, 129:1095-1096.
2. Shepherd S: Radiotherapy and the management of metastatic
bone pain.  Clin Radiol 1988, 39:547-550.
3. Harrington KD: The management of acetabular insufficiency
secondary to metastatic malignant disease.  JBJS Am 1981,
63A:653-664.
4. Wunder JS, Ferguson PC, Griffin AM, Pressman A, Bell RS: Acetab-
ular metastases: Planning for reconstruction and review of
results.  Clinical orthopaedics and related research 2003,
415S:187-197.
5. Ryan JR, Begeman PC: The effects of filling experimental large
cortical defects with methylmethacrylate.  Clin Orthop Relat Res
1984:306-10.
6. Healey JH, Shannon F, Boland P, DiResta GR: PMMA to stabilize
bone and deliver antineoplastic and antiresorptive agents.
Clin Orthop Relat Res 2003:S263-75.
7. Galibert P, Deramond H, Rosat P, Le Gars D: Preliminary note on
the treatment of vertebral angioma by percutaneous acrylic
vertebroplasty.  Neurochirurgie 1987, 33(2):166-8.
8. Deramond H, Depriester C, Galibert P, Le Gars D: Percutaneous
vertebroplasty with polymethylmethacrylate. Technique,
indications, and results.  Radiol Clin North Am 1998, 36(3):533-46.
9. Phillips FM, Pfeifer BA, Lieberman IH, Kerr EJ 3rd, Choi IS, Pazianos
AG: Minimally invasive treatments of osteoporotic vertebral
compression fractures: vertebroplasty and kyphoplasty.  Instr
Course Lect 2003, 52:559-67.
10. Lieberman I, Reinhardt MK: Vertebroplasty and kyphoplasty for
osteolytic vertebral collapse.  Clin Orthop Relat Res 2003:S176-86.
11. Cotten A, Deprez X, Migaud H, Chabanne B, Duquesnoy B, Chasta-
net P: Malignant acetabular osteolyses: percutaneous injec-
tion of acrylic bone cement.  Radiology 1995, 197(1):307-10.
12. Cotten A, Demondion X, Boutry N, Cortet B, Chastanet P, Duques-
noy B, Leblond D: Therapeutic percutaneous injections in the
treatment of malignant acetabular osteolyses.  Radiographics
1999, 19(3):647-53.
13. Hierholzer J, Anselmetti G, Fuchs H, Depriester C, Koch K, Pappert
D:  Percutaneous osteoplasty as a treatment for painful
malignant bone lesions of the pelvis and femur.  J Vasc Interv
Radiol 2003, 14(6):773-7.
14. Clohisy DR, Manthy PW: Bone cancer pain.  Cancer 2003,
97(S3):866-87.
15. Mirel H: The classic metastasis disease n long bones scoring
system for diagnosis impending pathologic fractures.  Clin
Orthop Relat Res 2003:S4-S13.
16. Galanis EC: Supportive measures: carcinoma metastatic to
bone.  I n  Orthopaedic Knowledge Update. Muscoloskeletal Tumours
Edited by: Menendez L. Rosemont, III: American Academy of Ortho-
paedic surgeons; 2002:331-342. 
17. Papagelopoulos PJ: Carcinoma metastatic to bone: nonsurgical
management.  I n  Orthopaedic Knowledge Update. Muscoloskeletal
Tumours Edited by: Menendez L. Rosemont, III: American Academy of
Orthopaedic surgeons; 2002:343-348. 
18. Hokotate H, Baba Y, Churei H, Nakajo M, Ohkubo K, Hamada K:
Pain palliation by percutaneous acetabular osteoplasty for
metastatic hepatocellular carcinoma.  Cardiovasc Intervent Radiol
2001, 24(5):346-48.
19. Harty JA, Brennan D, Eustace S, O'Byrne J: Percutaneous cemen-
toplasty of acetabular bony metastasis.  Surgeon 2003,
1(1):48-50.
20. Marcy PY, Palussiere J, Descamps B, Magne N, Bondiau PY, Ciais C,
Bruneton JN: Percutaneous cementoplasty for pelvic bone
metastasis.  S Care Cancer 8(6):500-3.
21. Weill A, Kobaiter H, Chiras J: Acetabulum malignancies: tech-
nique and impact on pain of percutaneous injection of acrylic
surgical cement.  Eur Radiol 1998, 8(1):123-9.
22. Toyota N, Naito A, Kakizawa H, Hieda M, Hirai N, Tachikake T,
Kimura T, Fukuda H, Ito K: Radiofrequency ablation therapy
combined with cementoplasty for painful bone metastases:
initial experience.  Cardiovasc Intervent Radiol 2005, 28(5):578-83.
23. Schaefer O, Lohrmann C, Herling M, Uhrmeister P, Langer M: Com-
bined radiofrequency thermal ablation and percutaneous
cementoplasty treatment of a pathologic fracture.  J Vasc
Interv Radiol 2002, 13(10):1047-50.
24. Li Z, Butala NB, Etheridge BS, Siegel HJ, Lemons JE, Eberhardt AW: A
biomechanical study of periacetabular defects and cement
filling.  J Biomech Eng 2007, 129(2):129-36.
25. Higgins KB, Harten RD, Langrana NA, Reiter MF: Biomechanical
Effects of Unipedicular Vertebroplasty on Intact Vertebrae.
Spine 2003, 28(14):1540-1547.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2474/9/66/prepub